Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA
スポンサーリンク
概要
- 論文の詳細を見る
An siRNA that specifically silences the expression of mRNA is a potential therapeutic agent for dealing with many diseases including cancer. However, the poor cellular uptake and bioavailability of siRNA remains a major obstacle to clinical development. For efficient delivery to tumor tissue, the pharmacokinetics and intracellular trafficking of siRNA must be rigorously controlled. To address this issue, we developed a liposomal siRNA carrier, a multi-functional nano device (MEND). We describe herein an approach for systemic siRNA delivery to tumors by combining the MEND system with shGALA, a fusogenic peptide. In cultured cell experiments, shGALA-modification enhanced the endosomal escape of siRNA encapsulated in a polyethylene glycol modified MEND (PEG-MEND), resulting in an 82% knockdown of the target gene. In vivo systemic administration clarified that the shGALA-modified MEND (shGALA-MEND) showed 58% gene silencing in tumor tissues at a dose of 4 mg of siRNA/kg body weight. In addition, a significant inhibition of tumor growth was observed only for the shGALA-MEND and no somatic or hepatic toxicity was observed. Given the above data, this peptide-modified delivery system, a shGALA-MEND has great potential for the systemic delivery of therapeutic siRNA aimed at cancer therapy.
論文 | ランダム
- Schnurri-2 は骨形成及び骨吸収を促進する骨リモデリングの新規調節因子である
- 粒子線(炭素イオン線)治療後のPET装置による照射範囲の画像化
- Current Topics in Pharmacological Research on Bone Metabolism : Regulation of Bone Mass by the Function of Endogenous Modulators of Bone Morphogenetic Protein in Adult Stage
- 骨髄の再構築と骨形成の分子制御 (特集 骨の中がいま面白い--骨・軟骨の形成から造血・免疫・癌転移との関わりまで)
- メカニカルストレスへの応答性の分子機構